DOI: 10.1097/01.ICB.0000256938.94801.ff
,
,
PMID: 25390226
Issn Print: 1935-1089
Publication Date: 2007/01/01
NEUROSENSORY MACULAR DETACHMENT IN GROUP 2A JUXTAFOVEOLAR TELANGIECTASIS AND RESOLUTION FOLLOWING INTRAVITREAL TRIAMCINOLONE
Sri Maguluri; Cynthia C. Recchia; Franco M. Recchia
Excerpt
A 55-year-old woman was referred for vitreoretinal evaluation because of 1 year of blurred vision. Ocular history was remarkable for an isolated episode of iritis in the left eye over 10 years previously. Medical history was significant for hypertension, hyperlipidemia, and noninsulin dependent diabetes mellitus. Her best-corrected visual acuity (BCVA) was 20/40 in the right eye and 20/70 in the left. Anterior segment examination was remarkable only for moderate nuclear sclerosis bilaterally. Funduscopy revealed a cup-to-disk ratio of 0.5 in the right eye and 0.7 in the left, normal vasculature, and no diabetic retinopathy. Blunting of the foveal reflex, parafoveolar telangiectasis, a yellow foveal lesion, and a neurosensory detachment were observed in both eyes (Figure 1A). Fluorescein angiography revealed retinal telangiectasias and capillary dilatation temporal to the foveola and intraretinal leakage (Figure 1B). Optical coherence tomography (OCT) revealed a macular neurosensory detachment in both eyes (Figure 1C). A diagnosis of group 2A juxtafoveolar telangiectasis (JFT) was made. An intravitreal injection of 4 mg of triamcinolone acetonide (Kenalog-40, Bristol Myers-Squibb, New York, NY) was administered to the left eye without complication. One month later, the same treatment was given to the right eye. BCVA improved to 20/25 bilaterally within 2 months of injections and has remained at that level for over 9 months. The improvement in vision was accompanied by a resolution of submacular fluid and a diminution in the foveal vitelliform lesion and resolution of the neurosensory detachment by OCT (Figure 2).
Facebook
Twitter
LinkedIn
Email
